首页> 外国专利> INHIBITION OF MARCKS-MEDIATED DEGRANULATION BY MARCKS N-TERMINAL PEPTIDES IN TREATING INFLAMMATION

INHIBITION OF MARCKS-MEDIATED DEGRANULATION BY MARCKS N-TERMINAL PEPTIDES IN TREATING INFLAMMATION

机译:N末端肽对马克介导的脱粒的抑制作用

摘要

The present invention includes methods of inhibiting or suppressing cellular secretory processes. More specifically the present invention relates to inhibiting or reducing the release of inflammatory mediators from inflammatory cells by inhibiting the mechanism associated with the release of inflammatory mediators from granules in inflammatory cells. In this regard, the present invention discloses an intracellular signaling mechanism that illustrates several novel intracellular targets for pharmacological intervention in disorders involving secretion of inflammatory mediators from vesicles in inflammatory cells. Peptide fragments and variants thereof of MANS peptide as disclosed in the present invention are useful in such methods. The present invention also discloses MARCKS protein and the inhibition of MARCKS-mediated degranulation to prevent release of inflammatory mediators by N-terminal peptides of MARCKS.
机译:本发明包括抑制或抑制细胞分泌过程的方法。更具体地,本发明涉及通过抑制与炎性细胞从颗粒中释放炎性介质有关的机制来抑制或减少炎性介质从炎性细胞中的释放。在这方面,本发明公开了一种细胞内信号传导机制,其举例说明了几种新的细胞内靶标,用于在涉及炎性细胞中囊泡分泌炎性介质的疾病中进行药理干预。如本发明中公开的MANS肽的肽片段及其变体可用于此类方法。本发明还公开了MARCKS蛋白和对MARCKS介导的脱粒的抑制,以防止由MARCKS的N端肽释放炎性介质。

著录项

  • 公开/公告号CA2842219C

    专利类型

  • 公开/公告日2017-07-11

    原文格式PDF

  • 申请/专利权人 BIOMARCK PHARMACEUTICALS LTD.;

    申请/专利号CA20072842219

  • 发明设计人 PARIKH INDU;

    申请日2007-07-26

  • 分类号A61K38/17;A61K9/72;A61P11;A61P29;

  • 国家 CA

  • 入库时间 2022-08-21 13:34:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号